A comparison of remifentanil patient-controlled analgesia with epidural analgesia during labor

Phase 3

• Conditions: laborpain; 10010273

• Registration Number: NL-OMON30922
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

age: 18 or older
between 37 and 42 weeks of gestation
singleton pregnancy
ASA physical status I or II

Exclusion Criteria

ASA physical status III or more
Morbid obesity (BMI 40 kg/m2 or more)
Substance abuse history
High risk patients: including pre-eclampsia, severe asthma, insulin dependent diabetes mellitus)
premature labor
drug allergy
cervical dilation 5cm or more

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>A. Quality of pain relief as determined by Visual Analogue Scale scores<br /><br>B. Patient satisfaction<br /><br>C. Fetal outcome as determined by Apgar scores, umbilical cord pH, NACS<br /><br>and<br /><br>requirement for naloxone</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>